Ian Gilron MD, MSc, FRCPC
Affiliated with the Queen's University Pain Research Group
Job Title: Director of Clinical Pain Research, Departments of Anesthesiology and Pharmacology & Toxicology, Queen's University
Dr. Ian Gilron is an anesthesiologist and Director of Clinical Pain Research at the Kingston General Hospital and Queen’s University in Kingston, Ontario, Canada. He is currently funded by the Canadian Institutes of Health Research (CIHR) and Ontario’s Physician Services Incorporated Foundation (PSI) to develop novel clinical trial methodologies for the study of both acute and chronic pain treatment. After receiving his M.D. (University of Ottawa), completing his anesthesiology residency (McGill University) and becoming a fellow of the Royal College of Physicians of Canada, Dr. Gilron received an M.Sc. degree in Neurological Sciences (McGill University) and completed a clinical trials fellowship at the U.S. National Institutes of Health. His research team’s current focus includes analgesic drug interactions as well as combination pharmacotherapy for the treatment of postoperative and neuropathic pain. Dr. Gilron is currently Principal Investigator on two Queen’s University analgesic combination trials in neuropathic pain (CIHR-funded) and postoperative pain (PSI-funded) and is also Principal Investigator (as well as Queen’s University site investigator) on a Canada-wide, industry-sponsored, multicenter (32 sites) neuropathic pain treatment trial. Recent work from Dr. Gilron’s team at Queen’s University has been published in the New England Journal of Medicine, CMAJ, Pain, Anesthesiology and various other journals. Dr. Gilron currently serves on the board of councillors of the Canadian Society for Clinical Investigation, has served on two panels for the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) and recently co-authored the Canadian Pain Society consensus statement and guidelines on neuropathic pain treatment.
Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL.
Morphine, gabapentin, or their combination for neuropathic pain.
N Engl J Med. 2005 Mar 31;352(13):1324-34.
Gilron I, Orr E, Tu D, O'Neill JP, Zamora JE, Bell AC.
A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy.
Pain. 2005 Jan;113(1-2):191-200.
Gilron I, Watson CP, Cahill CM, Moulin DE.
Neuropathic pain: a practical guide for the clinician.
CMAJ. 2006 Aug 1;175(3):265-75.
Gilron I, Milne B, Hong M.
Cyclooxygenase-2 inhibitors in postoperative pain management: current evidence and future directions.
Anesthesiology. 2003 Nov;99(5):1198-208.
Deshpande MA, Holden RR, Gilron I.
The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction?
Anesth Analg. 2006 May;102(5):1473-9.
Gilron I, Tod D, Goldstein DH, Parlow JL, Orr E.
The relationship between movement-evoked versus spontaneous pain and peak expiratory flow after abdominal hysterectomy.
Anesth Analg. 2002 Dec;95(6):1702-7.
Gilron I, Max MB.
Combination pharmacotherapy for neuropathic pain: current evidence and future directions.
Expert Rev Neurother. 2005 Nov;5(6):823-30.
Gilron I, Coderre TJ.
Emerging drugs in neuropathic pain.
Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.
Odrcich M, Bailey JM, Cahill CM, Gilron I.
Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy.
Pain. 2006 Jan;120(1-2):207-12.
Information last updated 2009-06-22.